Market closed

Palvella Therapeutics Inc/$PVLA

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Palvella Therapeutics Inc

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Ticker

$PVLA
Trading on

Industry

Biotechnology

Employees

14

PVLA Metrics

BasicAdvanced
$281M
-
-$7.83
-
-
$281M
$29.27
$18.23
96K
7.33
7.139
19.075
19.075
-3.26%
-18.39%
-59.37%
4.48
4.48
-5.23
-460.93%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $PVLA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Palvella Therapeutics Inc stock?

Palvella Therapeutics Inc (PVLA) has a market cap of $281M as of April 25, 2025.

What is the P/E ratio for Palvella Therapeutics Inc stock?

The price to earnings (P/E) ratio for Palvella Therapeutics Inc (PVLA) stock is 0 as of April 25, 2025.

Does Palvella Therapeutics Inc stock pay dividends?

No, Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders as of April 25, 2025.

When is the next Palvella Therapeutics Inc dividend payment date?

Palvella Therapeutics Inc (PVLA) stock does not pay dividends to its shareholders.

What is the beta indicator for Palvella Therapeutics Inc?

Palvella Therapeutics Inc (PVLA) does not currently have a Beta indicator.